Malignant paraganglioma arising from the kidney. 2007

Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
Department of Urology, Toyota Memorial Hospital, Toyota, Japan. yamanao@gifu-u.ac.jp

Paragangliomas are rare neoplasms arising from undifferentiated cells of the primitive neural crest. We report a case of a 34-year-old patient with renal paraganglioma. Complete surgical resection of the tumor was performed without intraoperative incident. The diagnosis was made based on immunohistochemical and ultramicroscopic analyses. The postoperative course was uneventful. Based on the obtained results, we discuss the clinical aspects of the case and the diagnosis.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D010235 Paraganglioma A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992) Paraganglioma, Gangliocytic,Paragangliomata,Gangliocytic Paraganglioma,Gangliocytic Paragangliomas,Paragangliomas,Paragangliomatas
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy

Related Publications

Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
April 1987, Gan no rinsho. Japan journal of cancer clinics,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
November 2024, JCEM case reports,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
March 1976, Archives of surgery (Chicago, Ill. : 1960),
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
August 1981, IMJ. Illinois medical journal,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
December 1999, Hiroshima journal of medical sciences,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
January 1952, A.M.A. archives of pathology,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
June 2011, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
May 2013, Journal of cardiac surgery,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
November 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Naoki Yamamoto, and Shinichi Maeda, and Yoshikazu Mizoguchi
March 2023, BMJ case reports,
Copied contents to your clipboard!